Literature DB >> 20664360

Preconditioning with high mobility group box 1 (HMGB1) induces lipoteichoic acid (LTA) tolerance.

Stephen M Robert1, Hanna Sjodin, Mitchell P Fink, Rajesh K Aneja.   

Abstract

High mobility group box chromosomal protein 1 (HMGB1) is a DNA-binding protein that exhibits proinflammatory properties when present in the extracellular compartment. Putative receptors for HMGB1 include Toll-like receptor (TLR)4, TLR2, and the receptor for advanced glycation end products (RAGE). We tested the hypothesis that extracellular HMGB1 can induce tolerance to the bacterial product, lipoteichoic acid (LTA). Pretreatment of human monocyte-like THP-1 cells with 1 μg/mL HMGB1 18 hours before exposure to LTA (10 μg/mL) decreased secretion of tumor necrosis factor, nuclear factor-κB DNA-binding, and degradation of IκBα. Denaturation of HMGB1 with boiling water or coincubation with anti-HMGB1 antibody abrogated the induction of tolerance to LTA. In contrast, coincubation with polymyxin B failed to diminish HMGB1-induced tolerance to LTA. These findings support the view that the induction of LTA tolerance by HMGB1 was not due to lipopolysaccharide contamination. Bone marrow-derived macrophages obtained from C57Bl/6 wild-type and RAGE-deficient mice became LTA-tolerant after HMGB1 exposure ex vivo. We were unable to demonstrate LTA tolerance in TLR2 and TLR4-deficient macrophages, as they are hyporesponsive to LTA. These findings suggest that extracellular HMGB1 induces LTA tolerance, and RAGE receptor is not required for this induction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20664360      PMCID: PMC2954270          DOI: 10.1097/CJI.0b013e3181dcd111

Source DB:  PubMed          Journal:  J Immunother        ISSN: 1524-9557            Impact factor:   4.456


  51 in total

Review 1.  HMGB1 as a late mediator of lethal systemic inflammation.

Authors:  H Wang; H Yang; C J Czura; A E Sama; K J Tracey
Journal:  Am J Respir Crit Care Med       Date:  2001-11-15       Impact factor: 21.405

Review 2.  HMGB1 as a DNA-binding cytokine.

Authors:  Ulf Andersson; Helena Erlandsson-Harris; Huan Yang; Kevin J Tracey
Journal:  J Leukoc Biol       Date:  2002-12       Impact factor: 4.962

Review 3.  Endotoxin tolerance: a review.

Authors:  Michael A West; Wyrta Heagy
Journal:  Crit Care Med       Date:  2002-01       Impact factor: 7.598

4.  HMG-1 as a mediator of acute lung inflammation.

Authors:  E Abraham; J Arcaroli; A Carmody; H Wang; K J Tracey
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

5.  Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14.

Authors:  Espen Ellingsen; Siegfried Morath; Trude Flo; Andra Schromm; Thomas Hartung; Christoph Thiemermann; Terje Espevik; Douglas Golenbock; Daniel Foster; Rigmor Solberg; Ansgar Aasen; Jacob Wang
Journal:  Med Sci Monit       Date:  2002-05

6.  Lipopolysaccharide- and lipoteichoic acid-induced tolerance and cross-tolerance: distinct alterations in IL-1 receptor-associated kinase.

Authors:  Randy Jacinto; Thomas Hartung; Charles McCall; Liwu Li
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

7.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation.

Authors:  Paola Scaffidi; Tom Misteli; Marco E Bianchi
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

Review 8.  Endotoxin tolerance: is there a clinical relevance?

Authors:  Jean-Marc Cavaillon; Christophe Adrie; Catherine Fitting; Minou Adib-Conquy
Journal:  J Endotoxin Res       Date:  2003

9.  The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells.

Authors:  B Degryse; T Bonaldi; P Scaffidi; S Müller; M Resnati; F Sanvito; G Arrigoni; M E Bianchi
Journal:  J Cell Biol       Date:  2001-03-19       Impact factor: 10.539

10.  A green tea-derived polyphenol, epigallocatechin-3-gallate, inhibits IkappaB kinase activation and IL-8 gene expression in respiratory epithelium.

Authors:  Philip C Chen; Derek S Wheeler; Vivek Malhotra; Kelli Odoms; Alvin G Denenberg; Hector R Wong
Journal:  Inflammation       Date:  2002-10       Impact factor: 4.092

View more
  10 in total

1.  Identification of tetranectin-targeting monoclonal antibodies to treat potentially lethal sepsis.

Authors:  Weiqiang Chen; Xiaoling Qiang; Yongjun Wang; Shu Zhu; Jianhua Li; Ariella Babaev; Huan Yang; Jonathan Gong; Lance Becker; Ping Wang; Kevin J Tracey; Haichao Wang
Journal:  Sci Transl Med       Date:  2020-04-15       Impact factor: 17.956

Review 2.  Targeting HMGB1 in the treatment of sepsis.

Authors:  Haichao Wang; Mary F Ward; Andrew E Sama
Journal:  Expert Opin Ther Targets       Date:  2014-01-06       Impact factor: 6.902

3.  Poly(ADP-ribose) polymerase 1-sirtuin 1 functional interplay regulates LPS-mediated high mobility group box 1 secretion.

Authors:  Thomas D Walko; Valentina Di Caro; Jon Piganelli; Timothy R Billiar; Robert S B Clark; Rajesh K Aneja
Journal:  Mol Med       Date:  2015-03-12       Impact factor: 6.354

Review 4.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

Review 5.  The role of high mobility group box 1 in innate immunity.

Authors:  Shin-Ae Lee; Man Sup Kwak; Sol Kim; Jeon-Soo Shin
Journal:  Yonsei Med J       Date:  2014-09       Impact factor: 2.759

6.  HMGB1/TLR4 Signaling Affects Regulatory T Cells in Acute Lung Injury.

Authors:  Min Zhou; Yadi Zhang; Rui Tang; Haiyan Liu; Min Du; Zhi Gao; Zongshu Ji; Haoshu Fang
Journal:  J Inflamm Res       Date:  2021-04-19

Review 7.  Endogenous Regulation and Pharmacological Modulation of Sepsis-Induced HMGB1 Release and Action: An Updated Review.

Authors:  Cassie Shu Zhu; Wei Wang; Xiaoling Qiang; Weiqiang Chen; Xiqian Lan; Jianhua Li; Haichao Wang
Journal:  Cells       Date:  2021-08-27       Impact factor: 6.600

8.  Attenuation of myocardial injury by HMGB1 blockade during ischemia/reperfusion is toll-like receptor 2-dependent.

Authors:  Jan Mersmann; Franziska Iskandar; Kathrina Latsch; Katharina Habeck; Vera Sprunck; René Zimmermann; Ralf R Schumann; Kai Zacharowski; Alexander Koch
Journal:  Mediators Inflamm       Date:  2013-11-24       Impact factor: 4.711

9.  The oxido-metabolic driver ATF4 enhances temozolamide chemo-resistance in human gliomas.

Authors:  Daishi Chen; Manfred Rauh; Michael Buchfelder; Ilker Y Eyupoglu; Nicolai Savaskan
Journal:  Oncotarget       Date:  2017-05-09

Review 10.  Targeting Inflammation Driven by HMGB1.

Authors:  Huan Yang; Haichao Wang; Ulf Andersson
Journal:  Front Immunol       Date:  2020-03-20       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.